Skip to main content
OpenTrials
Completed

NCT Number: NCT01032603

Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent Exotropia

The purpose of this study is to evaluate the effectiveness of bilateral lateral rectus muscle recession versus unilateral lateral rectus recession with medial rectus resection procedures for the treatment of basic type and pseudo divergence excess type intermittent exotropia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Exotropia Cranial Nerve Diseases Eye Diseases Nervous System Diseases Ocular Motility Disorders Strabismus

Age range

3 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vanderbilt Children's Hospital

Nashville, Tennessee, 37232-8808, United States

About this study

Intermittent exotropia (IXT) is the most common form of childhood onset exotropia with an incidence of 32.1 per 100,000 in children under 19 years of age. Intermittent exotropia is characterized by an exotropia that is not constant and is mainly present when viewing at distance, but may also be present at near. Normal binocular single vision (BSV) is typically present at near when the exotropia is controlled, with evidence of normal (occasionally sub-normal) stereoacuity. Although the natural history of the condition is largely unknown, many children with IXT are treated using either surgical or non-surgical interventions. The rationale for intervention in childhood IXT is that extended periods of misalignment may lead to entrenched suppression, resulting in loss of BSV. Intervention may also aim to address the social effects caused by the appearance of misaligned eyes. Many children treated for IXT are currently treated surgically.

There is poor agreement as to which type of surgery is most effective for the correction of IXT and the debate has long been related to differentiation between IXT sub-types. Based on distance-near angle disparity, IXT sub-types are classified as: 1) basic (similar magnitude of misalignment at distance and near); 2) true divergence excess (larger at distance); 3) pseudo divergence excess (initially larger at distance, but near angle increases following occlusion or with addition of plus lenses at near); 4) convergence insufficiency (larger at near). Basic and pseudo divergence excess appear to be the most common of the sub-types, and are also the types for which there is most disagreement regarding the optimum surgical approach. The two most common procedures are bilateral lateral rectus recession (BLRrec) and unilateral lateral rectus recession combined with a medial rectus resection in the same eye (R&R). Traditionally, BLRrec has been advocated where there is a larger distance angle, and R&R where there is a similar angle at distance and near. A survey of American strabismus surgeons published in 1990 found that the majority performed BLRrec for both basic and divergence excess types. Similarly, we found by polling our investigator group that the majority still perform a BLRrec for basic type IXT. Nevertheless, controversy still exists as to which of these surgical approaches is superior. Advocates of the BLRrec procedure tend to hold that surgery should be based purely on the distance angle of deviation. Proponents of R&R surgery suggest resection of the medial rectus best addresses the exodeviation at near.

The proposed advantage of the R&R procedure is that resecting the medial rectus, with a possible longer term initial overcorrection, is necessary for a stable and superior long-term outcome. Nevertheless, those who favor the BLRrec procedure suggest that the more profound and prolonged initial overcorrection occurring with R&R is not only unnecessary, but may in fact be harmful. A persistent overcorrection may be associated with the development of diplopia, amblyopia, and loss of stereoacuity. On the other hand, critics of the BLRrec procedure suggest that long-term recurrence rates are higher. Poor motor outcomes are likely to require reoperation and therefore the long-term success rates of these surgeries have public health importance in terms of cost to society.

Evaluating initial and long-term surgical outcomes in the proposed randomized clinical trial (RCT) will answer questions regarding the failure rates of these surgeries and also provide needed data on the potential harm of each procedure.

Only one prospective randomized clinical trial addresses success rates of BLRrec versus R&R for IXT. After between 12-15 months of follow up, 82% of 17 patients undergoing an R&R had a satisfactory outcome compared to 52% of 19 patients undergoing a BLRrec. Nevertheless, there are some important limitations of this previous study. The sample size was very small. The study population was a sub-group of patients with basic type IXT, excluding patients with basic IXT whose angle of deviation increased at far distance or following occlusion, thus limiting the generalizability of the results. In addition, outcomes were assessed unmasked, potentially biasing the results. One observational study of 103 patients (90% of whom had basic type IXT) found 1-year success rates of 56% for BLRrec and 60% for R&R. A retrospective study of 115 patients with basic type IXT reported success rates of 69% for BLRrec and 77% for R&R after an average of 15 months of follow up. Other studies comparing surgery types are limited not only by retrospective study design but also by inclusion of other types of exotropia, making it difficult to interpret results. In addition, many different criteria for success are used, precluding meaningful comparison of success rates between studies. This lack of evidence makes it very difficult to counsel parents of children with IXT regarding the likely success and complication rate of either procedure, limiting our ability to make informed management decisions. Establishing the respective failure rates through the proposed study will allow physicians to offer patients the type of surgery with the highest chance of long-term success, minimizing suboptimal results and repeat surgeries.

The present study is being conducted to compare the effectiveness of BLRrec with R&R for the surgical treatment of basic type and pseudo divergence excess type IXT.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 3 to < 11 years
  • Intermittent exotropia (manifest deviation) meeting all of the following:
  • Intermittent exotropia at distance OR constant exotropia at distance and either intermittent exotropia or exophoria at near
  • Largest exodeviation at either distance, near OR remote distance between 15 and 50 prism diopters (PD) (inclusive) by prism and alternate cover test (PACT)
  • Exodeviation at least 15 PD at distance and near by PACT
  • Basic type or pseudo divergence excess type
  • Stereoacuity of 400 arcsec or better at near by Preschool Randot stereotest (better of 2 measures)
  • Visual acuity in the worse eye at least 0.3 logMAR (20/40 on ATS HOTV or 70 letters on E-ETDRS)
  • No interocular difference of visual acuity more than 0.2 logMAR (2 lines on ATS HOTV or 10 letters on E-ETDRS testing)
  • Absence of high AC/A ratio (exclude > 6:1)
  • No previous intraocular surgery, strabismus surgery, or botulinum toxin treatment
  • Investigator planning to perform surgery for correction of IXT
  • No hyperopia greater than +3.50 D spherical equivalent (SE) in either eye

Exclusion criteria

  • Coexisting vertical deviation, oblique muscle dysfunction, dissociated vertical deviation (DVD), or A or V pattern, any of which the investigator plans to address with vertical transposition of horizontal rectus muscles, oblique surgery, or vertical rectus muscle surgery, i.e., only small vertical deviations, oblique muscle dysfunction, DVD, and A or V patterns not requiring surgery are allowed
  • Limitation of ocular rotations due to restrictive or paretic strabismus
  • Craniofacial malformations affecting the orbits
  • Interocular visual acuity difference of more than 0.2 logMAR (2 lines on ATS HOTV for patients 3 to < 7 years old or 10 letters on E-ETDRS for patients ≥ 7 years old) and/or investigator plans to initiate amblyopia treatment at this time.
  • High AC/A ratio (exclude > 6:1 by gradient method)
  • Prior strabismus surgery or botulinum toxin injection
  • Ocular disorders that would reduce visual acuity (except refractive error)
  • Prior intraocular or refractive surgery
  • Significant neurological impairment such as cerebral palsy. Patients with mild speech and/or learning disabilities are eligible.
  • Investigator planning to change refractive correction at this time (if the patient is otherwise eligible, the investigator should consider prescribing refractive correction and bringing the patient back at a later time for enrollment).

Treatment and study plan

Bilateral lateral rectus recession (BLRc)

Procedure

Bilateral lateral rectus recession surgery

Other names: BLR, BLRc

Unilateral lateral rectus recession with medial rectus resection (R&R)

Procedure

A unilateral lateral rectus recession combined with a medial rectus resection in the same eye. Choice of eye at investigator discretion based on any interocular difference, position under anesthesia, fixation preference, or forced duction testing. Reason for choice of eye will be recorded.

Other names: R&R

Primary outcomes

  1. Number of Participants With Suboptimal Surgical Outcome as Assessed by Motor Alignment and Stereoacuity at Near by 3 Years

    Time frame: 3 years

    A participant's intermittent exotropia (IXT) was considered to be a suboptimal surgical outcome if at any visit occurring 6 months or later, ANY of the following criteria are present by masked examiner testing:

    • Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest
    • Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one must be before any dissociation) with a magnitude of ≥6Δ by SPCT, confirmed by a retest
    • Decrease in Randot Preschool near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest Participants who underwent reoperation (or treatment with botulinum toxin) without first meeting any of the above suboptimal surgical outcome criteria were also counted as suboptimal surgical outcomes in the primary analysis.

  2. Primary Outcome Measure Stratified by Sex

    Time frame: 3 years

    NIH-required analysis. Primary OM (stratified by sex):

    A participant's intermittent exotropia (IXT) was considered to be a suboptimal surgical outcome if at any visit occurring 6 months or later, ANY of the following criteria are present by masked examiner testing:

    • Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest
    • Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one must be before any dissociation) with a magnitude of ≥6Δ by SPCT, confirmed by a retest
    • Decrease in Randot Preschool near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest Participants who underwent reoperation (or treatment with botulinum toxin) without first meeting any of the above suboptimal surgical outcome criteria were also counted as suboptimal surgical outcomes in the primary analysis

  3. Primary Outcome Measure Stratified by Race

    Time frame: 3 years

    NIH-required analysis. Primary OM stratified by race:

    A participant's intermittent exotropia (IXT) was considered to be a suboptimal surgical outcome if at any visit occurring 6 months or later, ANY of the following criteria are present by masked examiner testing:

    • Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest
    • Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one must be before any dissociation) with a magnitude of ≥6Δ by SPCT, confirmed by a retest
    • Decrease in Randot Preschool near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest Participants who underwent reoperation (or treatment with botulinum toxin) without first meeting any of the above suboptimal surgical outcome criteria were also counted as suboptimal surgical outcomes in the primary analysis

  4. Primary Outcome Measure Stratified by Ethnicity

    Time frame: 3 years

    NIH-required analysis. POM stratified by ethnicity:

    A participant's intermittent exotropia (IXT) was considered to be a suboptimal surgical outcome if at any visit occurring 6 months or later, ANY of the following criteria are present by masked examiner testing:

    • Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest
    • Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one must be before any dissociation) with a magnitude of ≥6Δ by SPCT, confirmed by a retest
    • Decrease in Randot Preschool near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest Participants who underwent reoperation (or treatment with botulinum toxin) without first meeting any of the above suboptimal surgical outcome criteria were also counted as suboptimal surgical outcomes in the primary analysis

Secondary outcomes

  1. Patients With Exotropia by 3 Years

    Time frame: Enrollment to 3 years

    Exotropia ≥10Δ by simultaneous prism and cover test (SPCT) at distance or near, confirmed by a retest, by 3 years. Criteria was met before any reoperation, and regardless of whether suboptimal surgical outcome was met by another criteria.

  2. Patients With Constant Esotropia by 3 Years

    Time frame: Enrollment to 3 years

    Constant esotropia ≥6Δ by simultaneous prism and cover test (SPCT) at distance or near, confirmed by a retest, by 3 years. Criteria was met before any reoperation, and regardless of whether suboptimal surgical outcome was met by another criteria.

  3. Number of Participants With Stereo Loss by 3 Years

    Time frame: Enrollment to 3 years

    Decrease in Preschool Randot near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest, by 3 years. Criteria was met before any reoperation, and regardless of whether suboptimal surgical outcome was met by another criteria.

  4. Number of Participants With Exotropia Control at Distance at 3 Years

    Time frame: 3 years after enrollment

    Exotropia control at distance was assessed in all patients who completed the 3-year visit. Numeric values for exotropia control were assigned so that the following seven categories were created:

    Not applicable (no exodeviation) (0) No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

  5. Mean Distance Control at 3 Years

    Time frame: 3 years after enrollment

    Mean exotropia control at distance was assessed in all patients who completed the 3-year visit. All 3-year visit data will be analyzed regardless of what treatment(s) a patient has received and regardless of whether the patient has undergone reoperation. Control at distance was analyzed as a continuous variable and compared between treatment groups using analysis of covariance (ANOVA) models that adjust for the corresponding baseline value (e.g. ANCOVA model of 3-year distance control will adjust for baseline distance control).

    Numeric values for exotropia control were assigned so that the following categories were created:

    Not applicable (no exodeviation) 0: No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

    Lower scores indicate better control.

  6. Change in Distance Exotropia Control at 3 Years

    Time frame: Enrollment to 3 years

    Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement.

    Numeric values for exotropia control were assigned so that the following categories were created:

    Not applicable (no exodeviation) 0: No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

    Lower scores indicate better control.

  7. Number of Participants With Exotropia Control at Near at 3 Years

    Time frame: 3 years after enrollment

    Exotropia control at near was assessed in all patients who completed the 3-year visit.

    Numeric values for exotropia control were assigned so that the following categories were created:

    Not applicable (no exodeviation) 0: No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

    Lower scores indicate better control.

  8. Mean Near Control at 3 Years

    Time frame: 3 years after enrollment

    Mean exotropia control at near was assessed in all patients who completed the 3-year visit. All 3-year visit data will be analyzed regardless of what treatment(s) a patient has received and regardless of whether the patient has undergone reoperation. Control at near was analyzed as a continuous variable and compared between treatment groups using analysis of covariance (ANOVA) models that adjust for the corresponding baseline value (e.g. ANCOVA model of 3-year near control will adjust for baseline near control).

    Numeric values for exotropia control were assigned so that the following categories were created:

    Not applicable (no exodeviation) 0: No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

    Lower scores indicate better control.

  9. Change in Near Exotropia Control at 3 Years

    Time frame: Enrollment to 3 Years

    Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement.

    Numeric values for exotropia control were assigned so that the following categories were created:

    Not applicable (no exodeviation) 0: No exotropia unless dissociated, recovers <1 secs (phoria)

    • No exotropia unless dissociated, recovers 1-5 secs
    • No exotropia unless dissociated, recovers >5 secs
    • Exotropia <50% of 30-second observation
    • Exotropia >50% of 30-second observation
    • Constant exotropia

    Lower scores indicate better control.

  10. Number of Participants With Distance PACT at 3 Years

    Time frame: 3 years after enrollment

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. PACT was assessed in all patients who completed the 3-year visit.

    ∆ = prism diopters; eso = esodeviation; exo = exodeviation

  11. Mean Distance PACT at 3 Years

    Time frame: 3 years after enrollment

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. Mean PACT was assessed in all patients who completed the 3-year visit. All 3-year visit data will be analyzed regardless of what treatment(s) a patient has received and regardless of whether the patient has undergone reoperation. PACT was analyzed as a continuous variable and compared between treatment groups using analysis of covariance (ANOVA) models that adjust for the corresponding baseline value (e.g. ANCOVA model of 3-year PACT at distance will adjust for baseline PACT at distance).

  12. Change in Distance PACT From Baseline to 3 Years

    Time frame: Enrollment to 3 years

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement. If the 3-year PACT is an esodeviation, change in PACT from baseline is the reduction in the exodeviation plus the amount of the 3-year exodeviation.

  13. Number of Participants With Near PACT at 3 Years

    Time frame: 3 years after enrollment

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. PACT was assessed in all patients who completed the 3-year visit.

    ∆ = prism diopters; eso = esodeviation; exo = exodeviation

  14. Mean Near PACT at 3 Years

    Time frame: 3 years after enrollment

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. Mean PACT was assessed in all patients who completed the 3-year visit. All 3-year visit data will be analyzed regardless of what treatment(s) a patient has received and regardless of whether the patient has undergone reoperation. PACT was analyzed as a continuous variable and compared between treatment groups using analysis of covariance (ANOVA) models that adjust for the corresponding baseline value (e.g. ANCOVA model of 3-year PACT at near will adjust for baseline PACT at near).

  15. Change in Near PACT From Baseline to 3 Years

    Time frame: Enrollment to 3 years

    The prism and alternate cover test (PACT) is used to measure the angle of strabismus, or deviation, in prism diopters. This is measured separately at distance and at near. Smaller numbers are better because they indicate a smaller angle of deviation. Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement. If the 3-year PACT is an esodeviation, change in PACT from baseline is the reduction in the exodeviation plus the amount of the 3-year exodeviation.

  16. Participants With Near Stereoacuity Measures at 3 Years

    Time frame: 3 years after enrollment

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    Stereoacuity Testing: stereoacuity was assessed in current refractive correction using the following:

    Preschool Randot stereotest at near (performed at 40 cm): If stereoacuity is worse than 40 arcsec, it must be retested and the better of the 2 measurements will be used for eligibility.

    Distance Randot stereotest (performed at 3 meters)

  17. Mean Near Stereoacuity at 3 Years

    Time frame: 3 years after enrollment

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    A logarithm base 10 transformation was used to convert stereoacuity scores to the log scale to calculate descriptive statistics (reported as seconds of arc, or arcsec).

    Stereoacuity Testing: stereoacuity was assessed in current refractive correction using the following:

    Preschool Randot stereotest at near (performed at 40 cm): If stereoacuity is worse than 40 arcsec, it must be retested and the better of the 2 measurements will be used for eligibility.

    Distance Randot stereotest (performed at 3 meters)

  18. Change in Near Stereoacuity From Baseline to 3 Years

    Time frame: Enrollment to 3 years

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    A logarithm base 10 transformation was used to convert stereoacuity scores to the log scale to calculate descriptive statistics (reported as seconds of arc, or arcsec).

    Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement.

  19. Participants Distance Stereoacuity at 3 Years

    Time frame: 3 years after enrollment

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    Stereoacuity Testing: stereoacuity was assessed in current refractive correction using the following:

    Preschool Randot stereotest at near (performed at 40 cm): If stereoacuity is worse than 40 arcsec, it must be retested and the better of the 2 measurements will be used for eligibility.

    Distance Randot stereotest (performed at 3 meters)

  20. Mean Distance Stereoacuity at 3 Years

    Time frame: 3 years after enrollment

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    A logarithm base 10 transformation was used to convert stereoacuity scores to the log scale to calculate descriptive statistics (reported as seconds of arc, or arcsec).

    Stereoacuity Testing: stereoacuity was assessed in current refractive correction using the following:

    Preschool Randot stereotest at near (performed at 40 cm): If stereoacuity is worse than 40 arcsec, it must be retested and the better of the 2 measurements will be used for eligibility.

    Distance Randot stereotest (performed at 3 meters)

  21. Change in Distance Stereoacuity From Baseline to 3 Years

    Time frame: Enrollment to 3 years

    Stereoacuity scores (seconds of arc) were calculated based on the Randot Preschool stereoacuity test (scores: 800, 400, 200, 100, 60 and 40). Seconds of arc refers to the visual angle that is being measured in order to determine depth perception. Lower scores indicate better stereoacuity.

    A logarithm base 10 transformation was used to convert stereoacuity scores to the log scale to calculate descriptive statistics (reported as seconds of arc, or arcsec).

    Change is defined as the baseline value minus the 3-year value, therefore positive change = improvement.

  22. Health Related Quality of Life

    Time frame: 3 years after enrollment

    Health-related quality of life will be assessed using the Intermittent Exotropia Questionnaire (IXTQ). This questionnaire consists of 6 components:

    • Child questionnaire - consists of 12 items which assess how the child feels about his/her eye condition.
    • One version for children aged 5 to < 8 years has a 3-level response scale
    • The version for children aged 8 years and older has a 5-level response scale
    • Parent proxy questionnaire - consists of 12 items which assess how the parent feels the child's eye condition affects the child
    • Parental questionnaire - consists of 17 items which assess how the child's eye condition affects the parent. Has 3 sub-scales: surgical, functional, and psycho-social.

    All scales ranged from 0 to 100; higher values indicated a better quality of life. Sub-scales were not combined, but rather were each evaluated individually on a scale of 0-100.

  23. Cumulative Number of Patients With Reoperation by 3 Years

    Time frame: 3 years after enrollment

    The cumulative proportion of re-operation by 3 years was compared between treatment groups using methods similar to the primary analysis (i.e. using Kaplan-Meier method). A treatment-group difference and a corresponding 95% confidence interval were also calculated. Reasons for re-operation included:

    XT; XT and worsening stereo ; XT, worsening stereo and social concerns ; XT, diplopia, and headaches ; XT and squinting with one eye closed ; ET ; ET, worsening stereo, and diplopia; ET, worsening stereo and social concerns ; ET, worsening stereo, social concerns, and amblyopia ; Inferior oblique overaction

  24. Number of Participants With Complete or Near-Complete Resolution at 3 Years

    Time frame: 3 years after enrollment

    Complete or near-complete resolution was defined as meeting all of the following at the 3 year visit: 1) exodeviation <10 Δ (tropia or phoria) by both SPCT and PACT at distance and near and ≥10 Δ reduction in PACT magnitude from the largest of the distance and near angles at enrollment, 2) esotropia <6 Δ at distance and near by SPCT, 3) no decrease in Randot Preschool stereoacuity of ≥2 octaves from the enrollment stereoacuity or to nil, 4) no reoperation or treatment with botulinum toxin, and 5) no non-surgical treatment for a recurrent or residual exodeviation.

  25. Participants Suboptimal Surgical Outcome at 3 Years

    Time frame: 3 years after enrollment

    Suboptimal surgical outcome at the 3-year visit was defined as meeting any of the three suboptimal surgical outcome criteria at the 3-year visit (regardless of whether the criterion had been met at an earlier visit), or undergoing reoperation at any time.

    The three criteria for suboptimal surgical outcome were:

    • Exotropia at distance OR near at any time during the exam (i.e., can be constant or intermittent; determined by a cover/uncover test) with a magnitude of ≥10Δ by SPCT, confirmed by a retest
    • Constant esotropia at distance OR near (determined by at least 3 cover/uncover tests-one must be before any dissociation) with a magnitude of ≥6Δ by SPCT, confirmed by a retest
    • Decrease in Randot Preschool near stereoacuity ≥2 octaves (≥0.6 log arcsec) from enrollment, or to nil, confirmed by a retest

Sponsors and collaborators

Lead sponsor

Jaeb Center for Health Research

Other

Collaborators

  • National Eye Institute (NEI)
  • Pediatric Eye Disease Investigator Group

Registry information

Official study title

A Randomized Trial of Bilateral Lateral Rectus Recession Versus Unilateral Lateral Rectus Recession With Medial Rectus Resection for Intermittent Exotropia

Acronym: IXT1

Important dates

Study start
2010
Primary completion
2017
Study completion
2022
First posted
Dec 15, 2009
Registry last updated
Jul 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.